1. Home
  2. CVM vs BMTX Comparison

CVM vs BMTX Comparison

Compare CVM & BMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • BMTX
  • Stock Information
  • Founded
  • CVM 1983
  • BMTX 2015
  • Country
  • CVM United States
  • BMTX United States
  • Employees
  • CVM N/A
  • BMTX N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • BMTX Major Banks
  • Sector
  • CVM Health Care
  • BMTX Finance
  • Exchange
  • CVM Nasdaq
  • BMTX Nasdaq
  • Market Cap
  • CVM 35.7M
  • BMTX 40.4M
  • IPO Year
  • CVM 1987
  • BMTX N/A
  • Fundamental
  • Price
  • CVM $0.56
  • BMTX $4.87
  • Analyst Decision
  • CVM
  • BMTX Buy
  • Analyst Count
  • CVM 0
  • BMTX 3
  • Target Price
  • CVM N/A
  • BMTX $6.70
  • AVG Volume (30 Days)
  • CVM 459.4K
  • BMTX 363.2K
  • Earning Date
  • CVM 12-19-2024
  • BMTX 11-14-2024
  • Dividend Yield
  • CVM N/A
  • BMTX N/A
  • EPS Growth
  • CVM N/A
  • BMTX N/A
  • EPS
  • CVM N/A
  • BMTX N/A
  • Revenue
  • CVM N/A
  • BMTX $57,298,000.00
  • Revenue This Year
  • CVM N/A
  • BMTX $6.32
  • Revenue Next Year
  • CVM $3,412.81
  • BMTX $2.91
  • P/E Ratio
  • CVM N/A
  • BMTX N/A
  • Revenue Growth
  • CVM N/A
  • BMTX 1.53
  • 52 Week Low
  • CVM $0.54
  • BMTX $1.45
  • 52 Week High
  • CVM $3.23
  • BMTX $4.87
  • Technical
  • Relative Strength Index (RSI)
  • CVM 14.93
  • BMTX 78.23
  • Support Level
  • CVM $0.54
  • BMTX $4.71
  • Resistance Level
  • CVM $0.92
  • BMTX $4.79
  • Average True Range (ATR)
  • CVM 0.06
  • BMTX 0.05
  • MACD
  • CVM -0.02
  • BMTX -0.02
  • Stochastic Oscillator
  • CVM 5.18
  • BMTX 100.00

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About BMTX BM Technologies Inc.

BM Technologies Inc provides digital banking and disbursement services to consumers and students nationwide through a full-service fintech banking platform, accessible to customers anywhere and anytime through digital channels. It facilitates deposits and banking services between a customer and its Partner Bank, Customers Bank, which is a related party and is a Federal Deposit Insurance Corporation (FDIC) insured bank. The company has four primary revenue sources: interchange and card revenue, servicing fees, account fees, and university fees. The majority of revenues are driven by customer activity (deposits, spending, transactions, etc.) and may be paid or passed through by customer banks, universities, or paid directly by customers.

Share on Social Networks: